The more tumors change, the more they stay tame: Do T cells keep POLE ultramutated endometrial carcinomas in check?

Gynecologic Oncology

Volumn 138, Issue 1, 2015, Pages 1-2

  Nelson, Brad H ^a,b,c   McAlpine, Jessica N ^b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF VICTORIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED DNA POLYMERASE EPSILON; DNA DIRECTED DNA POLYMERASE ALPHA; POLE PROTEIN, HUMAN;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; EDITORIAL; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; LEUKEMIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; POINT MUTATION; PRIORITY JOURNAL; SOMATIC MUTATION; SURVIVAL RATE; T LYMPHOCYTE; TUMOR IMMUNITY; ENDOMETRIUM TUMOR; ENZYMOLOGY; GENETICS; IMMUNOLOGY; MUTATION;

CD4-POSITIVE T-LYMPHOCYTES; DNA POLYMERASE II; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MUTATION;

EID: 84931433479     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.06.004     Document Type: Editorial

References (19)

1. T.N. Schumacher, and R.D. Schreiber Neoantigens in cancer immunotherapy Science 348 6230 2015 69 74
2. S.D. Brown, R.L. Warren, E.A. Gibb, S.D. Martin, J.J. Spinelli, and B.H. Nelson Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival Genome Res. 24 5 2014 743 750
3. M.S. Rooney, S.A. Shukla, C.J. Wu, G. Getz, and N. Hacohen Molecular and genetic properties of tumors associated with local immune cytolytic activity Cell 160 1-2 2015 48 61
4. N.A. Rizvi, M.D. Hellmann, A. Snyder, P. Kvistborg, V. Makarov, and J.J. Havel Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer Science 348 6230 2015 124 128
5. TCGA Integrated genomic analyses of ovarian carcinoma Nature 474 7353 2011 609 615
6. D.A. Wick, J.R. Webb, J.S. Nielsen, S.D. Martin, D.R. Kroeger, and K. Milne Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer Clin. Cancer Res. 20 5 2014 1125 1134
7. E. Heitzer, and I. Tomlinson Replicative DNA polymerase mutations in cancer Curr. Opin. Genet. Dev. 24 2014 107 113
8. Cancer Genome Atlas Research N, C. Kandoth, N. Schultz, A.D. Cherniack, R. Akbani, and Y. Liu Integrated genomic characterization of endometrial carcinoma Nature 497 7447 2013 67 73
9. D.N. Church, E. Stelloo, R.A. Nout, N. Valtcheva, J. Depreeuw, and N. ter Haar Prognostic significance of POLE proofreading mutations in endometrial cancer J. Natl. Cancer Inst. 107 1 2015 402
10. B. Meng, L.N. Hoang, J.B. McIntyre, M.A. Duggan, G.S. Nelson, and C.H. Lee POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium Gynecol. Oncol. 134 1 2014 15 19
11. C.C. Billingsley, D.E. Cohn, D.G. Mutch, J.A. Stephens, A.A. Suarez, and P.J. Goodfellow Polymerase varepsilon (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing Cancer 121 3 2015 386 394
12. A. Talhouk, M.K. McConechy, S. Leung, H.H. Li-Chang, J.S. Kwon, and N. Melnyk A clinically applicable molecular-based classification for endometrial cancers Br. J. Cancer 2015 (in press)
13. Y.R. Hussein, B. Weigelt, D.A. Levine, J.K. Schoolmeester, L.N. Dao, and B.L. Balzer Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations Mod. Pathol. 28 4 2015 505 514
14. D.N. Church, S.E. Briggs, C. Palles, E. Domingo, S.J. Kearsey, and J.M. Grimes DNA polymerase epsilon and delta exonuclease domain mutations in endometrial cancer Hum. Mol. Genet. 22 14 2013 2820 2828
15. E. Stelloo, T. Bosse, R.A. Nout, H.J. MacKay, D.N. Church, and H.W. Nijman Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative Mod. Pathol. 28 6 2015 836 844
16. I.C. van Gool, F.A. Eggink, L. Freeman-Mills, E. Stelloo, E. Marchi, and M. de Bruyn POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer Clin. Cancer Res. 2015
17. S. Bellone, F. Centritto, J. Black, C. Schwab, D. English, and E. Cocco Polymerase ε (POLE) ultra-mutated tumors induce robust tumor-specific CD4 + T cell responses in endometrial cancer patients Gynecol. Oncol. 138 1 2015 11 17 (in this issue)
18. G.T. Motz, and G. Coukos Deciphering and reversing tumor immune suppression Immunity 39 1 2013 61 73
19. G. Kroemer, L. Galluzzi, O. Kepp, and L. Zitvogel Immunogenic cell death in cancer therapy Annu. Rev. Immunol. 31 2013 51 72